Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2006 Nov;26(6):519-32.
doi: 10.1007/s10875-006-9047-x. Epub 2006 Oct 6.

Frequency and clinical manifestations of patients with primary immunodeficiency disorders in Iran: update from the Iranian Primary Immunodeficiency Registry

Affiliations

Frequency and clinical manifestations of patients with primary immunodeficiency disorders in Iran: update from the Iranian Primary Immunodeficiency Registry

Nima Rezaei et al. J Clin Immunol. 2006 Nov.

Abstract

Primary immunodeficiency disorders (PID) are a heterogeneous group of diseases, characterized by an increased susceptibility to infections. A total of 930 patients (573 males and 357 females) are registered in Iranian PID Registry (IPIDR) during three decades. Predominantly antibody deficiencies were the most common (38.4%), followed by congenital defects of phagocyte number and/or function (28.3%), other well-defined immunodeficiency syndromes (17.7%), combined T- and B-cell immunodeficiencies (11.0%), complement deficiencies (2.4%), and diseases of immune dysregulation (2.3%). Common variable immunodeficiency was the most frequent disorder (20.8%), followed by chronic granulomatous disease, ataxia-telangiectasia, btk deficiency, selective IgA deficiency, and T-B-severe combined immunodeficiency. The frequency of other PID disorders was less than 50 in number (<5%). There is an increasing trend in recognition of more PID in the recent years. Construction of such registry is not only important for its epidemiological aspect but also for its role in increasing the physician's knowledge about such disorders.

PubMed Disclaimer

References

    1. FEMS Immunol Med Microbiol. 2004 Mar 8;40(2):113-8 - PubMed
    1. J Pediatr Health Care. 2002 Jan-Feb;16(1):16-21 - PubMed
    1. J Clin Immunol. 1997 Jul;17(4):333-9 - PubMed
    1. J Clin Immunol. 2005 Mar;25(2):162-73 - PubMed
    1. Int Arch Allergy Immunol. 2006;141(4):408-14 - PubMed

Publication types

LinkOut - more resources